AYTU BIOPHARMA, INC Operating Lease, Weighted Average Discount Rate, Percent
AYTU BIOPHARMA, INC (AYTU) had Operating Lease, Weighted Average Discount Rate, Percent of 11.50% as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-09-22
- 2026-06-30: Operating Lease, Weighted Average Discount Rate, Percent 11.50%.
- 2026-03-31: Operating Lease, Weighted Average Discount Rate, Percent 11.40%.
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 11.40%.
- 2025-09-30: Operating Lease, Weighted Average Discount Rate, Percent 11.40%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent | Operating Lease, Weighted Average Discount Rate, Percent as first filed |
|---|---|---|
| 2026-06-30 | 11.50% 10-K · filed 2026-09-22 | |
| 2026-03-31 | 11.40% 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 11.40% 10-Q · filed 2026-02-03 | |
| 2025-09-30 | 11.40% 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 11.30% 10-K · filed 2026-09-22 | |
| 2025-03-31 | 11.20% 10-Q · filed 2025-05-14 | |
| 2024-12-31 | 12.10% 10-Q · filed 2025-02-12 | |
| 2024-09-30 | 11.10% 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 10.00% 10-K · filed 2025-09-23 | |
| 2024-03-31 | 9.18% 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 8.85% 10-Q · filed 2024-02-14 | |
| 2023-09-30 | 8.60% 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 7.80% 10-K · filed 2024-09-26 | 7.78% 10-K · filed 2023-10-12 |
| 2023-03-31 | 7.68% 10-Q · filed 2023-05-11 | |
| 2022-12-31 | 7.60% 10-Q · filed 2023-02-21 | |
| 2022-09-30 | 7.54% 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | 7.48% 10-K · filed 2023-10-12 | |
| 2022-03-31 | 7.44% 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 7.39% 10-Q · filed 2022-02-14 | |
| 2021-09-30 | 6.57% 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 6.62% 10-K · filed 2022-09-27 | |
| 2021-03-31 | 6.62% 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 8.00% 10-Q · filed 2021-02-11 | |
| 2020-09-30 | 8.00% 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 10.02% 10-K · filed 2021-09-28 | 8.09% 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |